CNS Drugs Take Longer to Develop, Win Approval

September 19, 2018

Drugs targeting the central nervous system take significantly longer to develop and get approved than other meds, according to a new analysis. In fact, the report cites that CNS drugs took 20% longer to develop and about 19 months (36%) longer on average than other meds to win FDA approval after clinical trials. 

No Previous Flipbooks

Next Flipbook
Identifying Elevated Rates of CDR Scoring Errors
Identifying Elevated Rates of CDR Scoring Errors

The goal of this study was to identify a CDR quality metric, based upon internal patterns of domain scores ...